Sign In
Buy BNTX
$90.58
-2.27 (-2.44%)
At Close: Jul 31, 2026
MAINZ, Germany, November 1, 2021 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”), a next generation immunotherapy company pioneering novel therapies for cancer a
Top 6 Momentum Picks for November After a Fabulous October
07:40am, Monday, 01'st Nov 2021
We have narrowed down our search to six large-cap momentum stocks that have strong upside left for the rest of 2021. These are: BX, Ce, CLR, XLNX, BG, GPC.
Novavax Is Finally Coming For BioNTech's Dominance
05:56pm, Thursday, 28'th Oct 2021
Comirnaty, the COVID-19 vaccine produced by Pfizer-BioNTech, has been recommended for children between 5 and 11 years old. The White House has acquired sufficient vaccines from Pfizer-BioNTech. It is
FDA's Adcomm Almost Unanimously Back Pfizer/BioNTech's COVID-19 Shots For Younger Kids
07:37am, Wednesday, 27'th Oct 2021
The FDA's Vaccines and Related Biological Products Advisory Committee voted 17-0 favor Pfizer Inc (NYSE: PFE) - BioNTech SE's (NASDAQ: BNTX) COVID-19 vaccine in younger children. With one panelis
BioNTech to Report Third Quarter Financial Results and Operational Update on November 9, 2021
07:00am, Wednesday, 27'th Oct 2021
Mainz, Germany, October 27, 2021 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter on Tuesday, November 9th
BioNTech SE Sponsored ADR (BNTX) Stock Sinks As Market Gains: What You Should Know
06:59pm, Tuesday, 26'th Oct 2021
BioNTech SE Sponsored ADR (BNTX) closed at $292.39 in the latest trading session, marking a -0.86% move from the prior day.
FDA advisors recommend BioNTech and Pfizer's COVID-19 shot for children
04:24pm, Tuesday, 26'th Oct 2021
A group of scientists who advise the Food and Drug Administration said the benefits of BioNTech BNTX, -0.86% and Pfizer's PFE, +0.95% COVID-19 vaccine outweigh the risks for children between the ages
